(Q39619266)

13 September 2017

title

Monte Carlo feature selection and rule-based models to predict Alzheimer's disease in mild cognitive impairment (English)

1 reference

mild cognitive impairment

13 September 2017

0 references

1 reference

1 reference

3

1 reference

13 September 2017

2

Henrik Zetterberg

1 reference

13 September 2017

7

Kaj Blennow

1 reference

13 September 2017

Sindre Rolstad

4

0 references

Lennart Minthon

5

object named as

Lennart Minthon

1 reference

13 September 2017

Marcin Kruczyk

1

1 reference

13 September 2017

Anders Wallin

6

1 reference

13 September 2017

Jan Komorowski

8

1 reference

13 September 2017

Mats Gunnar Andersson

9

1 reference

13 September 2017

publication date

10 May 2012

1 reference

Journal of Neural Transmission

13 September 2017

published in

1 reference

13 September 2017

volume

119

1 reference

13 September 2017

issue

7

1 reference

13 September 2017

page(s)

821-831

1 reference

Impaired cerebral glucose metabolism and cognitive functioning predict deterioration in mild cognitive impairment

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0812-0

Pinpointing plaques with PIB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0812-0

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0812-0

Combined 99mTc-ECD SPECT and neuropsychological studies in MCI for the assessment of conversion to AD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0812-0

Identifying Important Risk Factors for Survival in Kidney Graft Failure Patients Using Random Survival Forests

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0812-0

Prediction and longitudinal study of CSF biomarkers in mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0812-0

FDG-PET measurement is more accurate than neuropsychological assessments to predict global cognitive deterioration in patients with mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0812-0

MIST: Maximum Information Spanning Trees for dimension reduction of biological data sets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0812-0

Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0812-0

Combined rCBF and CSF biomarkers predict progression from mild cognitive impairment to Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0812-0

CSF Abeta42 and tau or phosphorylated tau and prediction of progressive mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0812-0

International quality control survey of neurochemical dementia diagnostics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0812-0

CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0812-0

The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0812-0

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0812-0

Reduced hippocampal metabolism in MCI and AD: automated FDG-PET image analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0812-0

The Goteborg MCI study: mild cognitive impairment is a heterogeneous condition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0812-0

Mild cognitive impairment as a diagnostic entity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0812-0

Cerebrospinal fluid tau and beta-amyloid 42 proteins identify Alzheimer disease in subjects with mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0812-0

Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0812-0

A worldwide multicentre comparison of assays for cerebrospinal fluid biomarkers in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0812-0

Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0812-0

Cerebrospinal fluid markers for prediction of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0812-0

Mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0812-0

Evaluation of CSF Biomarkers as Predictors of Alzheimer's Disease: A Clinical Follow-Up Study of 4.7 Years

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0812-0

Ridge Estimators in Logistic Regression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0812-0

Computational Analysis of Molecular Interaction Networks Underlying Change of HIV-1 Resistance to Selected Reverse Transcriptase Inhibitors.

21 January 2018

1 reference

12 December 2020

Intra-individual stability of CSF biomarkers for Alzheimer's disease over two years.

1 reference

12 December 2020

Value of CSF beta-amyloid1-42 and tau as predictors of Alzheimer's disease in patients with mild cognitive impairment.

1 reference

12 December 2020

Evaluation of CSF biomarkers as predictors of Alzheimer's disease: a clinical follow-up study of 4.7 years

1 reference

12 December 2020

10.1007/S00702-012-0812-0

Identifiers

DOI

1 reference

13 September 2017

1 reference